- Home
- BME vs ZVRA Comparison
BME vs ZVRA Comparison
Compare BME & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BME | ZVRA |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 547.5M | 472.9M |
| IPO Year | 2005 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BME | ZVRA |
|---|---|---|
| Price | $39.58 | $9.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 47.2K | ★ 769.1K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 159.21 |
| EPS | N/A | ★ 1.35 |
| Revenue | N/A | ★ $106,470,000.00 |
| Revenue This Year | N/A | $37.27 |
| Revenue Next Year | N/A | $53.42 |
| P/E Ratio | ★ N/A | $7.20 |
| Revenue Growth | N/A | ★ 350.91 |
| 52 Week Low | $35.03 | $6.77 |
| 52 Week High | $42.74 | $13.16 |
Technical Indicators
Market Signals| Indicator | BME | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 55.17 |
| Support Level | $37.71 | $8.29 |
| Resistance Level | $42.34 | $9.72 |
| Average True Range (ATR) | 0.86 | 0.39 |
| MACD | 0.19 | 0.01 |
| Stochastic Oscillator | 67.40 | 75.95 |
Price Performance
Historical ComparisonAbout BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.